Innovations in Dermatology: Brodalumab for Plaque Psoriasis

Article Type
Video
Changed
Thu, 12/15/2022 - 14:53
Display Headline
Innovations in Dermatology: Brodalumab for Plaque Psoriasis
Author(s)
Lawrence J. Green

Author and Disclosure Information

Dr. Green is a consultant, investigator, or speaker for AbbVie; Amgen Inc; Celgene Corporation; LEO Pharma; SunPharmaceutical Industries, Ltd; and Valeant Pharmaceuticals International Inc.

Publications
MDedge Dermatology
Cutis
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Sections
Clinical Topics & News
Author(s)
Lawrence J. Green
Author(s)
Lawrence J. Green
Author and Disclosure Information

Dr. Green is a consultant, investigator, or speaker for AbbVie; Amgen Inc; Celgene Corporation; LEO Pharma; SunPharmaceutical Industries, Ltd; and Valeant Pharmaceuticals International Inc.

Author and Disclosure Information

Dr. Green is a consultant, investigator, or speaker for AbbVie; Amgen Inc; Celgene Corporation; LEO Pharma; SunPharmaceutical Industries, Ltd; and Valeant Pharmaceuticals International Inc.

Publications
MDedge Dermatology
Cutis
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
MDedge Dermatology
Cutis
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Video
Display Headline
Innovations in Dermatology: Brodalumab for Plaque Psoriasis
Display Headline
Innovations in Dermatology: Brodalumab for Plaque Psoriasis
Sections
Clinical Topics & News
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Teaser Media
Subscribe to Lawrence J. Green